Point72 Asset Management, L.P. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19,532,396
-30.7%
2,758,813
-31.1%
0.06%
-32.1%
Q2 2023$28,193,088
+6218.6%
4,004,700
+7385.4%
0.08%
+8300.0%
Q1 2023$446,190
-98.0%
53,500
-97.3%
0.00%
-98.7%
Q4 2022$22,829,438
+235.0%
1,988,627
+208.7%
0.08%
+169.0%
Q2 2022$6,815,000
+1847.1%
644,100
+2448.7%
0.03%
+2800.0%
Q4 2021$350,000
-88.1%
25,272
-87.6%
0.00%
-92.3%
Q3 2021$2,930,000
-87.8%
203,913
-93.7%
0.01%
-88.9%
Q4 2020$24,069,000
+1007.6%
3,230,800
+410.7%
0.12%
+963.6%
Q3 2020$2,173,000
-48.6%
632,600
-28.7%
0.01%
-60.7%
Q2 2020$4,229,000
-29.9%
887,570
-70.6%
0.03%
-42.9%
Q1 2020$6,036,000
-79.1%
3,018,132
-64.0%
0.05%
-67.8%
Q4 2019$28,921,000
+209.6%
8,382,900
+157.1%
0.15%
+166.7%
Q3 2019$9,340,000
+2319.7%
3,260,000
+6770.0%
0.06%
+2750.0%
Q1 2019$386,000
-86.3%
47,453
-86.4%
0.00%
-85.7%
Q4 2018$2,825,000
-38.4%
350,000
-62.5%
0.01%
-30.0%
Q4 2017$4,585,000
+15183.3%
933,766
+46588.3%
0.02%
Q2 2015$30,0002,0000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders